Technology

Tricida

$7.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Tricida and other stocks, options, and ETFs commission-free!

About TCDA

Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA. The listed name for TCDA is Tricida, Inc. Common Stock.

CEO
Gerrit Klaerner
Employees
119
Headquarters
South San Francisco, California
Founded
2013
Market Cap
358.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
503.14K
High Today
$7.20
Low Today
$6.91
Open Price
$7.10
Volume
313.72K
52 Week High
$39.02
52 Week Low
$3.74

Collections

TCDA Earnings

-$1.46
-$0.97
-$0.49
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

LOV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure